2023 Q2 Form 10-K Financial Statement
#000173112223000637 Filed on April 12, 2023
Income Statement
Concept | 2023 Q2 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $131.4K | $336.1K | $1.198M |
YoY Change | -61.91% | 646.91% | 565.31% |
Cost Of Revenue | $148.8K | $287.8K | $817.8K |
YoY Change | -17.07% | ||
Gross Profit | -$17.41K | $48.36K | $379.8K |
YoY Change | -110.52% | 111.0% | |
Gross Profit Margin | -13.25% | 14.39% | 31.71% |
Selling, General & Admin | $190.6K | $661.9K | $1.414M |
YoY Change | -79.42% | -18.15% | -56.58% |
% of Gross Profit | 1368.65% | 372.2% | |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $334.5K | $611.9K | $3.178M |
YoY Change | -63.89% | -24.33% | -2.38% |
Operating Profit | -$351.9K | -$563.5K | -$2.798M |
YoY Change | -53.75% | -84.85% | |
Interest Expense | $359.3K | $3.460M | $969.6K |
YoY Change | -113.13% | -286.01% | -123.22% |
% of Operating Profit | |||
Other Income/Expense, Net | -$9.564M | $172.1K | $8.122M |
YoY Change | -16928.88% | -88.88% | 225.21% |
Pretax Income | -$9.916M | $3.068M | $5.324M |
YoY Change | 188.15% | -385.09% | -115.69% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$9.909M | $3.068M | $5.324M |
YoY Change | 187.96% | -385.09% | -115.69% |
Net Earnings / Revenue | -7540.02% | 912.88% | 444.56% |
Basic Earnings Per Share | $0.00 | $0.01 | |
Diluted Earnings Per Share | $0.00 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 2.930B shares | 1.207B shares | 696.7M shares |
Diluted Shares Outstanding | 28.49B shares | 4.647B shares |
Balance Sheet
Concept | 2023 Q2 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $56.57K | $122.8K | $122.8K |
YoY Change | -64.92% | -54.17% | -54.17% |
Cash & Equivalents | $44.07K | $93.58K | |
Short-Term Investments | $12.51K | $16.20K | $16.20K |
Other Short-Term Assets | $452.00 | $125.4K | $12.50K |
YoY Change | -99.9% | ||
Inventory | $12.86K | $11.57K | $11.57K |
Prepaid Expenses | |||
Receivables | $35.54K | $25.24K | $25.24K |
Other Receivables | $197.2K | $198.5K | $198.5K |
Total Short-Term Assets | $354.6K | $370.6K | $370.6K |
YoY Change | -50.38% | -90.78% | -90.78% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $354.6K | $370.6K | $370.6K |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $354.6K | $370.6K | $370.6K |
YoY Change | -50.38% | -90.78% | -90.78% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.029M | $1.531M | $1.531M |
YoY Change | -32.54% | 37.89% | 37.89% |
Accrued Expenses | $1.182M | $1.513M | $8.800M |
YoY Change | -84.72% | -84.68% | -10.9% |
Deferred Revenue | $36.44K | $41.44K | |
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $6.935M | $6.695M | $6.695M |
YoY Change | -27.91% | -39.01% | -39.01% |
Total Short-Term Liabilities | $31.05M | $18.89M | $18.89M |
YoY Change | 23.79% | -41.7% | -41.7% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $310.8K | $308.9K | $308.9K |
YoY Change | -11.72% | -17.28% | -17.28% |
Other Long-Term Liabilities | $0.00 | ||
YoY Change | |||
Total Long-Term Liabilities | $310.7K | $308.9K | $308.9K |
YoY Change | -11.72% | -17.28% | -17.28% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $31.05M | $18.89M | $18.89M |
Total Long-Term Liabilities | $310.7K | $308.9K | $308.9K |
Total Liabilities | $31.36M | $19.20M | $19.20M |
YoY Change | 23.3% | -41.42% | -41.42% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$314.8M | -$299.3M | |
YoY Change | -1.75% | ||
Common Stock | $55.51K | $15.36K | |
YoY Change | 4525.3% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $643.1K | $643.1K | |
YoY Change | 0.0% | ||
Treasury Stock Shares | |||
Shareholders Equity | -$31.05M | -$18.83M | -$18.83M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $354.6K | $370.6K | $370.6K |
YoY Change | -50.38% | -90.78% | -90.78% |
Cashflow Statement
Concept | 2023 Q2 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$9.909M | $3.068M | $5.324M |
YoY Change | 187.96% | -385.09% | -115.69% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$104.6K | -$471.7K | -$138.3K |
YoY Change | 1074.83% | 14.74% | -89.9% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | -$275.0K |
YoY Change | -100.0% | ||
Cash From Investing Activities | $0.00 | $0.00 | -$275.0K |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 89.57K | 53.01K | $364.8K |
YoY Change | -29.24% | -70.48% | -74.15% |
NET CHANGE | |||
Cash From Operating Activities | -104.6K | -471.7K | -$138.3K |
Cash From Investing Activities | 0.000 | 0.000 | -$275.0K |
Cash From Financing Activities | 89.57K | 53.01K | $364.8K |
Net Change In Cash | -14.99K | -418.7K | -$48.47K |
YoY Change | -53.62% | 80.82% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$104.6K | -$471.7K | -$138.3K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021 | GTCH |
Investment To Tghi
InvestmentToTghi
|
usd | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001471781 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022Q4 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
usd | |
CY2022Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
usd | |
CY2021Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
usd | |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
usd | |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
usd | |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
usd | |
CY2021Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
usd | |
CY2022Q4 | us-gaap |
Other Inventory In Transit
OtherInventoryInTransit
|
usd | |
CY2021Q4 | us-gaap |
Other Inventory In Transit
OtherInventoryInTransit
|
usd | |
CY2021Q4 | GTCH |
Investment Current
InvestmentCurrent
|
usd | |
CY2022Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
usd | |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
usd | |
CY2021Q4 | GTCH |
Due To Related Party Current
DueToRelatedPartyCurrent
|
usd | |
CY2022Q4 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021 | GTCH |
Sales
Sales
|
usd | |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
usd | |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
usd | |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
usd | |
CY2022 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
usd | |
CY2021 | GTCH |
Gain On Rjw Settlement
GainOnRjwSettlement
|
usd | |
CY2022 | us-gaap |
Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
|
usd | |
CY2021 | GTCH |
Change In Fair Value Of Marketable Securities
ChangeInFairValueOfMarketableSecurities
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | GTCH |
Common Stock Issued For Tokenize
CommonStockIssuedForTokenize
|
usd | |
CY2022 | GTCH |
Equity Method Investment Meta
EquityMethodInvestmentMeta
|
usd | |
CY2022 | GTCH |
Cancelation Of Shares
CancelationOfShares
|
usd | |
CY2022 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | |
CY2022 | us-gaap |
Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
|
usd | |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
usd | |
CY2022 | GTCH |
Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
|
usd | |
CY2022 | GTCH |
Loss On Exchange Of Assets
LossOnExchangeOfAssets
|
usd | |
CY2021 | GTCH |
Loss On Exchange Of Assets
LossOnExchangeOfAssets
|
usd | |
CY2021 | GTCH |
Change In Fair Value Of Marketable Securitie
ChangeInFairValueOfMarketableSecuritie
|
usd | |
CY2021 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
usd | |
CY2022 | GTCH |
Payment Of Other Income With Marketable Securities
PaymentOfOtherIncomeWithMarketableSecurities
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
usd | |
CY2022 | GTCH |
Increase Decrease In Cash Held In Trust
IncreaseDecreaseInCashHeldInTrust
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
usd | |
CY2021 | GTCH |
Investment To Gtx
InvestmentToGtx
|
usd | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2021 | GTCH |
Issuance Of Note Receivable
IssuanceOfNoteReceivable
|
usd | |
CY2021 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | |
CY2021 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
usd | |
CY2021 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
usd | |
CY2022 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2022 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2022 | GTCH |
Transfer Of Marketable Equity Security To Repay Convertible Note
TransferOfMarketableEquitySecurityToRepayConvertibleNote
|
usd | |
CY2021 | GTCH |
Share Issuance For Jv Metaverse
ShareIssuanceForJvMetaverse
|
usd | |
CY2021 | GTCH |
Share Issuance For Jv Tokenize
ShareIssuanceForJvTokenize
|
usd | |
CY2022 | GTCH |
Transfer Of Accounts Payable To Convertible Note
TransferOfAccountsPayableToConvertibleNote
|
usd | |
CY2022 | GTCH |
Transfer Of Accrued Interest To Convertible Note
TransferOfAccruedInterestToConvertibleNote
|
usd | |
CY2021 | GTCH |
Cancellation Of Ttsg Shares
CancellationOfTtsgShares
|
usd | |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
usd | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
usd | |
CY2022Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
usd | |
CY2022Q4 | GTCH |
Unamortized Debt Discount At Convertible Note Payable
UnamortizedDebtDiscountAtConvertibleNotePayable
|
usd | |
CY2021Q4 | GTCH |
Unamortized Debt Discount At Convertible Note Payable
UnamortizedDebtDiscountAtConvertibleNotePayable
|
usd | |
CY2022Q4 | GTCH |
Convertible Notes Payable Net Related Party Longterm Portion
ConvertibleNotesPayableNetRelatedPartyLongtermPortion
|
usd | |
CY2021Q4 | GTCH |
Convertible Notes Payable Net Related Party Longterm Portion
ConvertibleNotesPayableNetRelatedPartyLongtermPortion
|
usd | |
CY2022Q4 | GTCH |
Debt Instruments Unamortized Discount Current
DebtInstrumentsUnamortizedDiscountCurrent
|
usd | |
CY2021Q4 | GTCH |
Debt Instruments Unamortized Discount Current
DebtInstrumentsUnamortizedDiscountCurrent
|
usd | |
CY2022Q4 | GTCH |
Debt Instruments Unamortized Discount Current
DebtInstrumentsUnamortizedDiscountCurrent
|
usd | |
CY2021Q4 | GTCH |
Debt Instruments Unamortized Discount Current
DebtInstrumentsUnamortizedDiscountCurrent
|
usd | |
CY2022Q4 | GTCH |
Notes Payable Net Related Party Longterm Portion
NotesPayableNetRelatedPartyLongtermPortion
|
usd | |
CY2021Q4 | GTCH |
Notes Payable Net Related Party Longterm Portion
NotesPayableNetRelatedPartyLongtermPortion
|
usd | |
CY2019Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
usd | |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
usd | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
shares | |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
usd | |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
usd | |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
usd | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
000-54530 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
GBT TECHNOLOGIES INC. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
27-0603137 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2450 Colorado Ave. | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 100E | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Santa Monica | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
90404 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
888 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
685-7336 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
2266899 | usd |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
2930101819 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
5081 | |
CY2022 | dei |
Auditor Name
AuditorName
|
M.S. Madhava Rao | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Eastvale, CA | |
CY2022Q4 | us-gaap |
Cash
Cash
|
106639 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
155106 | usd |
CY2021Q4 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
112942 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
25244 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
11569 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
12500 | usd |
CY2022Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
198475 | usd |
CY2022Q4 | GTCH |
Investment Current
InvestmentCurrent
|
16198 | usd |
CY2021Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
3750000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
370625 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4018048 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
370625 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
4018048 | usd |
CY2022Q4 | GTCH |
Accounts Payable Related Parties Currents
AccountsPayableRelatedPartiesCurrents
|
1539802 | usd |
CY2021Q4 | GTCH |
Accounts Payable Related Parties Currents
AccountsPayableRelatedPartiesCurrents
|
2302928 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6240634 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6896263 | usd |
CY2022Q4 | GTCH |
Accrued Settlement
AccruedSettlement
|
4090057 | usd |
CY2021Q4 | GTCH |
Accrued Settlement
AccruedSettlement
|
4090057 | usd |
CY2022Q4 | us-gaap |
Unearned Premiums
UnearnedPremiums
|
48921 | usd |
CY2021Q4 | us-gaap |
Unearned Premiums
UnearnedPremiums
|
249384 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
41444 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
190464 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
362004 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
6397727 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
8109436 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
116605 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
116605 | usd |
CY2022Q4 | GTCH |
Debt Instrument Unamortized Discounts
DebtInstrumentUnamortizedDiscounts
|
0 | usd |
CY2021Q4 | GTCH |
Debt Instrument Unamortized Discounts
DebtInstrumentUnamortizedDiscounts
|
47671 | usd |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
41137 | usd |
CY2021Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2612397 | usd |
CY2022Q4 | GTCH |
Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
|
140000 | usd |
CY2021Q4 | GTCH |
Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
|
140000 | usd |
CY2022Q4 | GTCH |
Due To Related Party Current
DueToRelatedPartyCurrent
|
62003 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
1714143 | usd |
CY2021Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
10192485 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
18892671 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
32406629 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
88403 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
35797 | usd |
CY2022Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
308863 | usd |
CY2021Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
337603 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
19201534 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
32780029 | usd |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1535593440 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1535593440 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
33200198 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
33200198 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
15356 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
332 | usd |
CY2022Q4 | GTCH |
Treasury Stock Share
TreasuryStockShare
|
21 | shares |
CY2021Q4 | GTCH |
Treasury Stock Share
TreasuryStockShare
|
21 | shares |
CY2022Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
643059 | usd |
CY2021Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
643059 | usd |
CY2022Q4 | GTCH |
Stock Loan Receivable
StockLoanReceivable
|
-7610147 | usd |
CY2021Q4 | GTCH |
Stock Loan Receivable
StockLoanReceivable
|
-7610147 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
288664858 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
284072666 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-299257917 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-304581773 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18830909 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-28761981 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
370625 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4018048 | usd |
CY2022 | GTCH |
Sales
Sales
|
1152555 | usd |
CY2022 | GTCH |
Revenue From Related Party
RevenueFromRelatedParty
|
45000 | usd |
CY2021 | GTCH |
Revenue From Related Party
RevenueFromRelatedParty
|
180000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
1197555 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
180000 | usd |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
817754 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
379801 | usd |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
180000 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1053282 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
293628 | usd |
CY2022 | us-gaap |
Marketing Expense
MarketingExpense
|
360335 | usd |
CY2021 | us-gaap |
Marketing Expense
MarketingExpense
|
837614 | usd |
CY2022 | us-gaap |
Acquisition Costs
AcquisitionCosts
|
1814543 | usd |
CY2021 | us-gaap |
Acquisition Costs
AcquisitionCosts
|
2124272 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
15400000 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
50000 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
3178160 | usd |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
18655514 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2798359 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18475514 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
442247 | usd |
CY2021 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
824238 | usd |
CY2022 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
|
6594370 | usd |
CY2021 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
|
-1339117 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
969629 | usd |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
2022584 | usd |
CY2021 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
11000 | usd |
CY2022 | GTCH |
Gain On Rjw Settlement
GainOnRjwSettlement
|
3012355 | usd |
CY2021 | us-gaap |
Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
|
-13777480 | usd |
CY2022 | GTCH |
Change In Fair Value Of Marketable Securities
ChangeInFairValueOfMarketableSecurities
|
310462 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
237828 | usd |
CY2021 | us-gaap |
Other Income
OtherIncome
|
2497500 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
8122215 | usd |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-15454919 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
5323856 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-33930433 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
5323856 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-33930433 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5323856 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-33930433 | usd |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
696686911 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
19991381 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4646981551 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
19991381 | shares |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.70 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.70 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-27858304 | usd |
CY2021 | GTCH |
Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest
CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest
|
5678006 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
281750 | usd |
CY2021 | GTCH |
Common Stock Issued For Joint Venture
CommonStockIssuedForJointVenture
|
15400000 | usd |
CY2021 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
11666999 | usd |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-33930433 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-28761981 | usd |
CY2022 | GTCH |
Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest
CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest
|
2165461 | usd |
CY2022 | GTCH |
Fair Value Of Derivative Liability Due To Conversions
FairValueOfDerivativeLiabilityDueToConversions
|
2209888 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
231867 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
5323856 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18830909 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5323856 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-33930433 | usd |
CY2022 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
442247 | usd |
CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
824238 | usd |
CY2022 | GTCH |
Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
|
-6594370 | usd |
CY2021 | GTCH |
Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
|
1339117 | usd |
CY2022 | GTCH |
Excess Of Debt Discount And Financing Costs
ExcessOfDebtDiscountAndFinancingCosts
|
34175 | usd |
CY2021 | GTCH |
Excess Of Debt Discount And Financing Costs
ExcessOfDebtDiscountAndFinancingCosts
|
136785 | usd |
CY2021 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
281748 | usd |
CY2021 | us-gaap |
Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
|
-13777480 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
15400000 | usd |
CY2021 | GTCH |
Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
|
11000 | usd |
CY2022 | GTCH |
Change In Fair Value Of Marketable Securitie
ChangeInFairValueOfMarketableSecuritie
|
308802 | usd |
CY2022 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
3012633 | usd |
CY2021 | GTCH |
Payment Of Other Income With Marketable Securities
PaymentOfOtherIncomeWithMarketableSecurities
|
800000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
25244 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-3741525 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
3750000 | usd |
CY2021 | GTCH |
Increase Decrease In Cash Held In Trust
IncreaseDecreaseInCashHeldInTrust
|
289590 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
12500 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
11569 | usd |
CY2022 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-8556 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-200463 | usd |
CY2021 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-291 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-123462 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
5073651 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-138293 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1369114 | usd |
CY2022 | GTCH |
Investment To Gtx
InvestmentToGtx
|
150000 | usd |
CY2022 | GTCH |
Investment To Tghi
InvestmentToTghi
|
125000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-275000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
300000 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
1317386 | usd |
CY2022 | GTCH |
Issuance Of Note Receivable
IssuanceOfNoteReceivable
|
190000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
231864 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
-106200 | usd |
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
694225 | usd |
CY2022 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
39042 | usd |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
756227 | usd |
CY2021 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
200000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
364826 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1411186 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-48467 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
42072 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
155106 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
113034 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
106639 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
155106 | usd |
CY2021 | us-gaap |
Interest Paid
InterestPaid
|
2898 | usd |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
2898 | usd |
CY2022 | GTCH |
Debt Discount Related To Convertible Debt
DebtDiscountRelatedToConvertibleDebt
|
325916 | usd |
CY2021 | GTCH |
Debt Discount Related To Convertible Debt
DebtDiscountRelatedToConvertibleDebt
|
741100 | usd |
CY2022 | GTCH |
Reduction In Derivative Liability Due To Conversion
ReductionInDerivativeLiabilityDueToConversion
|
2209888 | usd |
CY2021 | GTCH |
Reduction In Derivative Liability Due To Conversion
ReductionInDerivativeLiabilityDueToConversion
|
11666999 | usd |
CY2022 | GTCH |
Shares Issued For Conversion Of Convertible Debt
SharesIssuedForConversionOfConvertibleDebt
|
2165464 | usd |
CY2021 | GTCH |
Shares Issued For Conversion Of Convertible Debt
SharesIssuedForConversionOfConvertibleDebt
|
5678006 | usd |
CY2021 | GTCH |
Transfer Of Marketable Equity Security To Repay Convertible Note
TransferOfMarketableEquitySecurityToRepayConvertibleNote
|
660000 | usd |
CY2022 | GTCH |
Share Issuance For Jv Metaverse
ShareIssuanceForJvMetaverse
|
5000 | usd |
CY2022 | GTCH |
Share Issuance For Jv Tokenize
ShareIssuanceForJvTokenize
|
1500 | usd |
CY2021 | GTCH |
Transfer Of Accounts Payable To Convertible Note
TransferOfAccountsPayableToConvertibleNote
|
424731 | usd |
CY2021 | GTCH |
Transfer Of Accrued Interest To Convertible Note
TransferOfAccruedInterestToConvertibleNote
|
202899 | usd |
CY2022 | GTCH |
Cancellation Of Ttsg Shares
CancellationOfTtsgShares
|
-2 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1 for 50 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000000 | shares |
CY2022 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-500 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-299257917 | usd |
CY2022 | GTCH |
Working Capital Deficit
WorkingCapitalDeficit
|
18552046 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_849_eus-gaap--UseOfEstimates_zrX0g7hjlssh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zOLIekEZtuS7">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p id="xdx_002_zrO0MIkTCCfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> | |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2022Q4 | us-gaap |
Restricted Cash Equivalents
RestrictedCashEquivalents
|
375000 | usd |
CY2022Q1 | us-gaap |
Escrow Deposit
EscrowDeposit
|
19694 | usd |
CY2022 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zE87gqsoYFae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zSoQAtXgqjvk">Reclassification</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | |
CY2022 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
100000 | usd |
CY2021Q3 | GTCH |
Stockholders Equitys
StockholdersEquitys
|
50000 | usd |
CY2022Q2 | GTCH |
Stockholders Equitys
StockholdersEquitys
|
50000 | usd |
CY2022 | us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<p id="xdx_84A_eus-gaap--DerivativesReportingOfDerivativeActivity_zabBPEYeQti8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_z76iOlCldVob">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022 and 2021, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | |
CY2022Q4 | GTCH |
Conversion Feature On Convertible Notes
ConversionFeatureOnConvertibleNotes
|
1714143 | usd |
CY2021Q4 | GTCH |
Conversion Feature On Convertible Notes
ConversionFeatureOnConvertibleNotes
|
10192485 | usd |
CY2022 | GTCH |
Weighted Average Exercise Price Warrants Exercisable At End
WeightedAverageExercisePriceWarrantsExercisableAtEnd
|
205.07 | |
CY2022 | GTCH |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms
|
P0Y3M18D | |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
48921 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
249384 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
41444 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
0 | usd |
CY2022Q1 | us-gaap |
Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
|
200000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
93581 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
11569 | usd |
CY2022Q4 | GTCH |
Due From Related Parties Currents
DueFromRelatedPartiesCurrents
|
20270 | usd |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
125420 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
94496 | usd |
CY2021Q4 | GTCH |
Impairment Charge
ImpairmentCharge
|
15400000 | usd |
CY2022Q4 | us-gaap |
Investments
Investments
|
0 | usd |
CY2021Q4 | us-gaap |
Investments
Investments
|
0 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
70770 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
70770 | shares |
CY2021Q4 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
10000000 | usd |
CY2022 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
3949223831 | shares |
CY2021 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
83722340 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3949360301 | shares |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
84180910 | shares |
CY2022Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.01 | |
CY2022 | GTCH |
Escrow Amount Received
EscrowAmountReceived
|
1000000 | usd |
CY2022 | GTCH |
Final Settlement Agreement Description
FinalSettlementAgreementDescription
|
SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022. | |
CY2022 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
4200000 | usd |
CY2022Q1 | GTCH |
Settlement Amount
SettlementAmount
|
3750000 | usd |
CY2022 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
3750000 | usd |
CY2021Q4 | GTCH |
Services Payable
ServicesPayable
|
33333 | usd |
CY2020Q1 | GTCH |
Impairment Charge
ImpairmentCharge
|
5500000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1530762 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1110127 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1513261 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3033016 | usd |
CY2022Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
3196611 | usd |
CY2021Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
2753120 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6240634 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6896263 | usd |
CY2018 | GTCH |
Cash Received In Connection With Intellectual Property License And Royalty Agreement
CashReceivedInConnectionWithIntellectualPropertyLicenseAndRoyaltyAgreement
|
200000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
48921 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
249384 | usd |
CY2022Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
6586788 | usd |
CY2021Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
8424100 | usd |
CY2022Q4 | GTCH |
Debt Instruments Unamortized Discount Noncurrent
DebtInstrumentsUnamortizedDiscountNoncurrent
|
-189060 | usd |
CY2021Q4 | GTCH |
Debt Instruments Unamortized Discount Noncurrent
DebtInstrumentsUnamortizedDiscountNoncurrent
|
-278867 | usd |
CY2022Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
6397727 | usd |
CY2021Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
8145233 | usd |
CY2022Q4 | GTCH |
Less Current Portion
LessCurrentPortion
|
6397727 | usd |
CY2021Q4 | GTCH |
Less Current Portion
LessCurrentPortion
|
-8109436 | usd |
CY2021Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
35797 | usd |
CY2022 | us-gaap |
Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
|
0.85 | pure |
CY2022 | GTCH |
Charge Related To Modification Of Debt
ChargeRelatedToModificationOfDebt
|
13777480 | usd |
CY2022 | GTCH |
Convertible Note Payable Description
ConvertibleNotePayableDescription
|
IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note | |
CY2021 | GTCH |
Convertible Note Payable Description
ConvertibleNotePayableDescription
|
IGOR 1 converted $1,659,869 of the convertible note into 590,117,647 shares of the Company’s common stock. | |
CY2020Q3 | GTCH |
Maturity Date Extension Fees
MaturityDateExtensionFees
|
1000 | usd |
CY2022Q4 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
6393497 | usd |
CY2021Q4 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
8145233 | usd |
CY2022Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
2068799 | usd |
CY2021Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
1547924 | usd |
CY2022Q4 | GTCH |
Convertible Note Payable To Stanley Hills
ConvertibleNotePayableToStanleyHills
|
116605 | usd |
CY2021Q4 | GTCH |
Convertible Note Payable To Stanley Hills
ConvertibleNotePayableToStanleyHills
|
116605 | usd |
CY2022Q4 | GTCH |
Other Convertible Notes Payable Current
OtherConvertibleNotesPayableCurrent
|
116605 | usd |
CY2021Q4 | GTCH |
Other Convertible Notes Payable Current
OtherConvertibleNotesPayableCurrent
|
116605 | usd |
CY2022Q4 | GTCH |
Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
|
-116605 | usd |
CY2021Q4 | GTCH |
Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
|
-116605 | usd |
CY2022Q4 | GTCH |
Total Notes Payables
TotalNotesPayables
|
350000 | usd |
CY2021Q4 | GTCH |
Total Notes Payables
TotalNotesPayables
|
2950000 | usd |
CY2022Q4 | GTCH |
Note Payables
NotePayables
|
350000 | usd |
CY2021Q4 | GTCH |
Note Payables
NotePayables
|
2950000 | usd |
CY2022Q4 | GTCH |
Current Portion Of Notes Payables
CurrentPortionOfNotesPayables
|
-41137 | usd |
CY2021Q4 | GTCH |
Current Portion Of Notes Payables
CurrentPortionOfNotesPayables
|
-2612397 | usd |
CY2022Q4 | GTCH |
Long Term Note Payables
LongTermNotePayables
|
308863 | usd |
CY2021Q4 | GTCH |
Long Term Note Payables
LongTermNotePayables
|
337603 | usd |
CY2022 | GTCH |
Schedule Of Note Payable Related Parties Table Textblock
ScheduleOfNotePayableRelatedPartiesTableTextblock
|
<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zn8abDs1Dstf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BB_zeM1c6FMfI8i" style="display: none">Schedule of notes payable related parties</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha Eda note payable</span></td><td style="width: 8%; font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20221231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total notes payable, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--TotalNotesPayableRelatedParties_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--TotalNotesPayableRelatedParties_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20221231_z2WeupVlCiYj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1461">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20211231_z18vS4c7SUW7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1463">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, net, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--NotesPayableRelatedParties_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NotesPayableRelatedParties_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(140,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--CurrentPortionOfNotePayableRelatedParties_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(140,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, net, related party, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1473">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1475">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> | |
CY2022Q4 | GTCH |
Total Notes Payable Related Parties
TotalNotesPayableRelatedParties
|
140000 | usd |
CY2021Q4 | GTCH |
Total Notes Payable Related Parties
TotalNotesPayableRelatedParties
|
140000 | usd |
CY2022Q4 | GTCH |
Notes Payable Related Parties
NotesPayableRelatedParties
|
140000 | usd |
CY2021Q4 | GTCH |
Notes Payable Related Parties
NotesPayableRelatedParties
|
140000 | usd |
CY2022Q4 | GTCH |
Current Portion Of Note Payable Related Parties
CurrentPortionOfNotePayableRelatedParties
|
-140000 | usd |
CY2021Q4 | GTCH |
Current Portion Of Note Payable Related Parties
CurrentPortionOfNotePayableRelatedParties
|
-140000 | usd |
CY2022Q4 | GTCH |
Accrued Settlement
AccruedSettlement
|
4090057 | usd |
CY2021Q4 | GTCH |
Accrued Settlement
AccruedSettlement
|
4090057 | usd |
CY2022Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.17 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0476 | pure |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2020 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
|
5767230 | usd |
CY2020 | GTCH |
Fair Value Of Beneficial Conversion Feature Of Debt Converted
FairValueOfBeneficialConversionFeatureOfDebtConverted
|
-2038392 | usd |
CY2020 | GTCH |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos
|
1533610 | usd |
CY2020Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
5262448 | usd |
CY2021 | GTCH |
Debt Modification
DebtModification
|
13777480 | usd |
CY2021 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
|
1480439 | usd |
CY2021 | GTCH |
Fair Value Of Beneficial Conversion Feature Of Debt Converted
FairValueOfBeneficialConversionFeatureOfDebtConverted
|
-116669 | usd |
CY2021 | GTCH |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos
|
1339117 | usd |
CY2021Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
10192485 | usd |
CY2022 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
|
325915 | usd |
CY2022 | GTCH |
Fair Value Of Beneficial Conversion Feature Of Debt Converted
FairValueOfBeneficialConversionFeatureOfDebtConverted
|
-2209887 | usd |
CY2022 | GTCH |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos
|
-6594370 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1714143 | usd |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
2000000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
2000000000 | shares |
CY2022 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
847133242 | shares |
CY2022 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
2158969 | usd |
CY2022 | GTCH |
Debt Conversion Converted Instrument Accrued Interest
DebtConversionConvertedInstrumentAccruedInterest
|
6491 | usd |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
|
240000 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
392870 | shares |
CY2022 | GTCH |
Weighted Average Exercise Price Warrants Outstanding Beginning
WeightedAverageExercisePriceWarrantsOutstandingBeginning
|
74.97 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P0Y9M3D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
70770 | shares |
CY2022 | GTCH |
Weighted Average Exercise Price Warrants Outstanding End
WeightedAverageExercisePriceWarrantsOutstandingEnd
|
205.07 | |
CY2022 | GTCH |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1
|
P0Y3M18D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
70770 | shares |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
9182327 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
8945238 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
9182327 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
8945238 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
9182327 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
8945238 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
237089 | usd |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
712442 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
31663196 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1118010 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-7125391 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
425908 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.080 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-2714435 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.080 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-1784116 | usd |
CY2022 | GTCH |
Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
|
-0.335 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
9127383 | usd |
CY2021 | GTCH |
Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
|
-0.269 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
237089 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.045 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
712442 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.021 | pure |
CY2022Q4 | GTCH |
Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
|
140000 | usd |
CY2021Q4 | GTCH |
Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
|
140000 | usd |
CY2020Q3 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
48844 | usd |
CY2020Q3 | GTCH |
Legal Cost
LegalCost
|
716 | usd |
CY2020Q4 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
48844 | usd |
CY2020Q4 | GTCH |
Legal Cost
LegalCost
|
716 | usd |
CY2022 | us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
<p id="xdx_80C_eus-gaap--LossContingencyDisclosures_zD2gPYOeJc4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: left"><b>Note 18 - <span id="xdx_820_zAvGRkwbSyY4">Contingencies</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zYaU9elNITya" title="Revenues">300,000 </span>which is nonrefundable. The Company recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_908_ecustom--PaymentForExpenses_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zVgMmn8NZpGc" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_907_eus-gaap--DeferredRevenue_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zfTg9oenR5n1" title="Unearned revenue">200,000</span> to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Assignment of lease agreement</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $<span id="xdx_90D_eus-gaap--OperatingExpenses_pp0p0_c20220501__20220517_zuDLkM9LBRv5" title="Operating expense">200</span> per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> | |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
200 | usd |